Profil
J.
Alan Butcher served as the Head of Research & Development at Purdue Pharma LP from 2015 to 2018.
He also worked as the Chief Corporate Development Officer at Lupin Ltd.
and as the Chief Business Officer & Executive Vice President at AMAG Pharmaceuticals, Inc. in 2018 and 2019 respectively.
Butcher received his undergraduate and graduate degrees from West Chester University of Pennsylvania and his undergraduate and graduate degrees from Johnson Graduate School of Management.
Anciens postes connus de J. Alan Butcher
| Sociétés | Poste | Fin |
|---|---|---|
| LUPIN LIMITED | Corporate Officer/Principal | 28/02/2022 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 20/12/2019 |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Corporate Officer/Principal | 01/04/2018 |
Formation de J. Alan Butcher
| West Chester University of Pennsylvania | Graduate Degree |
| Johnson Graduate School of Management | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LUPIN LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Purdue Pharma LP
Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
